Cellosaurus HEL/TGR (CVCL_4Z61)
| Cell line name | HEL/TGR |
|---|---|
| Accession | CVCL_4Z61 |
| Resource Identification Initiative | To cite this cell line use: HEL/TGR (RRID:CVCL_4Z61) |
| Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_90304; TG101209 (N-(tert-butyl)-3-((5-methyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide). Donor information: Originally the patient was suffering from Hodgkin lymphoma. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. |
| Sequence variations |
|
| Disease | Erythroleukemia (NCIt: C7152) Acute erythroid leukemia (ORDO: Orphanet_318) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_2481 (HEL 92.1.7) |
| Sex of cell | Male |
| Age at sampling | 30Y |
| Category | Cancer cell line |
| Publications | PubMed=21976548; DOI=10.1158/1078-0432.CCR-11-1541; PMCID=PMC3743080 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_4Z61 |
| Encyclopedic resources | Wikidata; Q54882508 |
| Entry history | |
| Entry creation | 14-Dec-2015 |
| Last entry update | 19-Dec-2024 |
| Version number | 12 |